Zealand Pharma A/S Debt to Equity Ratio 2018-2022 | ZEAL

Current and historical debt to equity ratio values for Zealand Pharma A/S (ZEAL) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Zealand Pharma A/S debt/equity for the three months ending March 31, 2022 was .
Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2022-03-31 $0.17B $0.11B 1.59
2021-12-31 $0.18B $0.15B 1.23
2021-09-30 $0.08B $0.19B 0.40
2021-06-30 $0.09B $0.23B 0.39
2021-03-31 $0.08B $0.27B 0.31
2020-12-31 $0.08B $0.19B 0.43
2020-09-30 $0.07B $0.25B 0.30
2020-06-30 $0.07B $0.27B 0.26
2020-03-31 $0.05B $0.18B 0.29
2019-12-31 $0.05B $0.19B 0.29
2019-09-30 $0.05B $0.21B 0.22
2019-06-30 $0.04B $0.15B 0.27
2019-03-31 $0.04B $0.17B 0.25
2018-12-31 $0.02B $0.17B 0.10
2018-09-30 $0.04B $0.19B 0.23
2018-06-30 $0.03B $0.05B 0.65
2018-03-31 $0.03B $0.07B 0.42
2017-12-31 $0.03B $0.08B 0.40
2017-09-30 $0.03B $0.10B 0.30
2017-06-30 $0.03B $0.03B 1.10
2017-03-31 $0.03B $0.04B 0.88